{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:47:02Z","timestamp":1793832422696,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","award":["CA- 826809"],"award-info":[{"award-number":["CA- 826809"]}],"id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.gendis.2026.102136","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:59:04Z","timestamp":1773161944000},"page":"102136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efineptakin alfa (NT-I7) improves overall survival and induces immune niches in murine tumors"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-9161","authenticated-orcid":false,"given":"Trang","family":"Dinh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namita","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijana","family":"Bjelivuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6217-7408","authenticated-orcid":false,"given":"Dathan","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1553-4266","authenticated-orcid":false,"given":"Jiasen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita L.","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7902-8935","authenticated-orcid":false,"given":"Alexandra A.","family":"Wolfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafi","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Skitzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1546-1080","authenticated-orcid":false,"given":"Zhenghe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-7108","authenticated-orcid":false,"given":"Rebecca C.","family":"Obeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6576","key":"10.1016\/j.gendis.2026.102136_bib1","doi-asserted-by":"crossref","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.gendis.2026.102136_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.gendis.2026.102136_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4049\/jimmunol.2000873","article-title":"Tertiary lymphoid structures: diversity in their development, composition, and role","volume":"206","author":"Gago da Gra\u00e7a","year":"2021","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102136_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2007.04.009","article-title":"Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells","volume":"26","author":"Meier","year":"2007","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.gendis.2026.102136_bib5","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.4049\/jimmunol.1001836","article-title":"Evolution of ectopic lymphoid Neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets","volume":"185","author":"Astorri","year":"2010","journal-title":"J Immunol"},{"issue":"7791","key":"10.1016\/j.gendis.2026.102136_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.gendis.2026.102136_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.gendis.2026.102136_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.gendis.2026.102136_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.gendis.2026.102136_bib10","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","article-title":"Flip the coin: IL-7 and IL-7R in health and disease","volume":"20","author":"Barata","year":"2019","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102136_bib11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4049\/jimmunol.162.3.1333","article-title":"Lymphotoxin alphabeta is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation","volume":"162","author":"Gramaglia","year":"1999","journal-title":"J Immunol"},{"issue":"36","key":"10.1016\/j.gendis.2026.102136_bib12","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1073\/pnas.0604183103","article-title":"Role of T and NK cells and IL7\/IL7r interactions during neonatal maturation of lymph nodes","volume":"103","author":"Coles","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.gendis.2026.102136_bib13","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.4049\/jimmunol.0802911","article-title":"Cutting edge: IL-7 regulates the peripheral pool of adult ROR gamma+ lymphoid tissue inducer cells","volume":"183","author":"Schmutz","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102136_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1084\/jem.20092029","article-title":"IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors","volume":"207","author":"Satoh-Takayama","year":"2010","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.gendis.2026.102136_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ni1330","article-title":"Lymphoid organ development: from ontogeny to Neogenesis","volume":"7","author":"Drayton","year":"2006","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.gendis.2026.102136_bib16","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.4049\/jimmunol.0803974","article-title":"Inflammation recapitulates the ontogeny of lymphoid stromal cells","volume":"182","author":"Peduto","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.gendis.2026.102136_bib17","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nri2832","article-title":"New insights into the development of lymphoid tissues","volume":"10","author":"van de Pavert","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102136_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/10.1.1","article-title":"Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage","volume":"10","author":"Adachi","year":"1998","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102136_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010291","article-title":"Phase I study of efineptakin Alfa (NT-I7) for the treatment of Kaposi sarcoma","volume":"13","author":"Ramaswami","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.gendis.2026.102136_bib20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41416-025-03069-3","article-title":"GX-I7, a long-acting IL-7, safely and effectively increased peripheral CD8+\/CD4+ T cells and TILs in patients with locally advanced or metastatic solid tumours","volume":"133","author":"Kim","year":"2025","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2026.102136_bib21","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1038\/s41467-022-30860-0","article-title":"A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity","volume":"13","author":"Kim","year":"2022","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.gendis.2026.102136_bib22","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1078-0432.CCR-21-0947","article-title":"Long-acting recombinant human interleukin-7, NT-I7, increases cytotoxic CD8 T cells and enhances survival in mouse glioma models","volume":"28","author":"Campian","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.gendis.2026.102136_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008001","article-title":"rhIL-7-hyFc and hIL-2\/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors","volume":"12","author":"Lee","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.gendis.2026.102136_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1477171","article-title":"Enabling immune checkpoint blockade efficacy in T-lymphopenia by restoring CD8 T cell dynamics with IL-7 cytokine therapy","volume":"15","author":"Kang","year":"2024","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.gendis.2026.102136_bib25","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1182\/bloodadvances.2023010032","article-title":"Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc","volume":"7","author":"O'Neal","year":"2023","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.gendis.2026.102136_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008989","article-title":"rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors","volume":"12","author":"Li","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.gendis.2026.102136_bib34","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.celrep.2018.10.047","article-title":"Analysis of single-cell RNA-seq identifies cell-cell communication associated with tumor characteristics","volume":"25","author":"Kumar","year":"2018","journal-title":"Cell Rep"},{"issue":"7620","key":"10.1016\/j.gendis.2026.102136_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gendis.2026.102136_bib28","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1073\/pnas.1917298117","article-title":"PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection","volume":"117","author":"Im","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"10.1016\/j.gendis.2026.102136_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221985120","article-title":"Characteristics and anatomic location of PD-1(+)TCF1(+) stem-like CD8 T cells in chronic viral infection and cancer","volume":"120","author":"Im","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.gendis.2026.102136_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.gendis.2026.102136_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)PD-1(+)CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.gendis.2026.102136_bib32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"issue":"7875","key":"10.1016\/j.gendis.2026.102136_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","article-title":"Functional HPV-specific PD-1(+) stem-like CD8 T cells in head and neck cancer","volume":"597","author":"Eberhardt","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.gendis.2026.102136_bib35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.183.4.1461","article-title":"Chronic inflammation caused by lymphotoxin is lymphoid Neogenesis","volume":"183","author":"Kratz","year":"1996","journal-title":"J Exp Med"},{"issue":"2\u20133","key":"10.1016\/j.gendis.2026.102136_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02786481","article-title":"Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development","volume":"19","author":"Ruddle","year":"1999","journal-title":"Immunol Res"},{"issue":"9","key":"10.1016\/j.gendis.2026.102136_bib37","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-11-2210","article-title":"A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin \u03ba C as a compatible prognostic marker in human solid tumors","volume":"18","author":"Schmidt","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gendis.2026.102136_bib38","article-title":"A novel tertiary lymphoid structure-associated signature accurately predicts patient prognosis and facilitates the selection of personalized treatment strategies for HNSCC","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102136_bib39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1074-7613(02)00479-X","article-title":"Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches","volume":"17","author":"Yoshida","year":"2002","journal-title":"Immunity"},{"issue":"7620","key":"10.1016\/j.gendis.2026.102136_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature19317","article-title":"Follicular CXCR5- expressing CD8+ T cells curtail chronic viral infection","volume":"537","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2026.102136_bib42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41590-024-01792-2","article-title":"Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy","volume":"25","author":"Chen","year":"2024","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102136_bib41","doi-asserted-by":"crossref","first-page":"eaai8593","DOI":"10.1126\/sciimmunol.aai8593","article-title":"The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness","volume":"1","author":"Wu","year":"2016","journal-title":"Sci Immunol"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235230422600108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235230422600108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:03:17Z","timestamp":1790146997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235230422600108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S235230422600108X"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2026.102136","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efineptakin alfa (NT-I7) improves overall survival and induces immune niches in murine tumors","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2026.102136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102136"}}